PPIs, Metformin, and Vitamin B-12: Are You at Risk for Deficiency?
"Uncover the surprising link between common medications and Vitamin B-12 deficiency – and what you can do to protect your health."
If you're among the millions who regularly take medications like proton pump inhibitors (PPIs) for heartburn, H2-receptor antagonists (H2RAs), or metformin for diabetes, it's important to be aware of a potential hidden risk: Vitamin B-12 deficiency. While these drugs are effective in treating their respective conditions, research indicates they can also interfere with your body's ability to absorb Vitamin B-12.
Vitamin B-12 is crucial for nerve function, red blood cell production, and DNA synthesis. A deficiency can lead to a range of health issues, from fatigue and weakness to neurological problems. That's why understanding how these common medications might impact your B-12 levels is essential for maintaining your overall well-being.
This article dives into the connection between PPIs, H2RAs, metformin, and Vitamin B-12 deficiency. We'll explore how these drugs can disrupt B-12 absorption, discuss the clinical implications of this deficiency, and provide practical steps you can take to protect your health. Find out what you need to know to stay informed and proactive about your Vitamin B-12 levels.
Mixed Evidence on PPI-Linked B12 Risk
Research on proton pump inhibitors (PPIs) and vitamin B12 status has produced conflicting findings. One 2022 study reported significantly lower B12 levels among omeprazole patients, with 54.12% affected, compared with 45.87% among pantoprazole patients. In contrast, another 2022 study found slightly higher B12 levels among PPI users, 320 pmol/L versus 300 pmol/L, while a systematic review and meta-analysis found no association between chronic PPI use and B12 deficiency.
Testing and Dose-Related Findings
Assessment of vitamin B12 status may use total serum B12 and total homocysteine, but a 2025 systematic review found no association between chronic PPI use and deficiency using those measures. Other evidence has reported increased risk in specific groups, including men younger than 18 years in one 2022 study. Dose may also matter: a JAMA study found that use of more than 1.5 PPI pills per day was more strongly associated with B12 deficiency than lower use, with an odds ratio of 1.95 (95% CI, 1.77-2.15).
From B12 Awareness to PPI Questions
Vitamin B12 has long been discussed as part of the B vitamin complex, and Harvard's Nutrition Source notes that supplements are often promoted for energy and mood. More recent public discussion has examined whether acid-reducing medicines, including PPIs, affect B12 status. A 2026 study reported that PPI use for six months or longer was associated with a clinically significant reduction in serum vitamin B12 levels, adding to the ongoing debate.
How Do These Medications Affect Vitamin B-12 Absorption?
To understand the potential impact of these medications, it's helpful to know how Vitamin B-12 is normally absorbed. The process is complex, involving several steps:
- Once freed, B-12 binds to a protein called R-binder (also known as haptocorrin) in the saliva and stomach.
- As the B-12/R-binder complex enters the small intestine, pancreatic enzymes release B-12.
- B-12 then binds to intrinsic factor (IF), a protein produced by the stomach.
- The B-12/IF complex travels to the ileum (the final part of the small intestine), where it's absorbed into the bloodstream. This absorption process relies on calcium.
- Finally, in the blood, B-12 binds to transcobalamin, a transport protein that delivers it to cells throughout the body.
Reviews Find No Consistent Association
A review published by Miller and colleagues examined vitamin B12 absorption and the mechanisms through which PPIs, H2-receptor antagonists, and metformin may affect these functions. However, a 2022 study of PPI users found slightly higher vitamin B12 levels among treated subjects. That study reported no association between PPI medication use and the outcomes it evaluated, underscoring that mechanistic concerns do not always translate into measurable deficiency.
Why the Evidence Remains Contested
Some evidence links long-term PPI therapy to vitamin B12 deficiency through reduced stomach acid, while other research has not found a consistent association. A 2025 review reported deficiency rates of up to 54.12% among omeprazole users, whereas other studies have reported null findings. The Mayo Clinic explains that acid-controlling medicines may reduce vitamin B12 absorption, but these competing observations show why medication use alone may not establish an individual's deficiency.
Comparing Medication-Related Risk
The available material does not establish a definitive comparison between PPIs, metformin, and other medication-related causes of vitamin B12 deficiency. Evidence about PPIs varies across studies, with some reporting lower B12 status and others finding no association. Comparisons should therefore account for the specific medicine, dose, duration, population, and testing method rather than treating all medication exposure as equivalent.
Protecting Your Vitamin B-12 Levels: What You Can Do
If you're taking PPIs, H2RAs, or metformin long-term, it's wise to be proactive about monitoring your Vitamin B-12 status. Talk to your doctor about getting your B-12 levels checked, especially if you experience symptoms like fatigue, weakness, or neurological issues.
A Possible but Unsettled Association
A systematic review reported that vitamin B12-deficient individuals had higher overall PPI exposure than individuals without deficiency, with an odds ratio of 1.49 (95% CI, 1.20-1.85; I2 = 68%). However, the same source noted that most studies found no association. Taken together, the evidence suggests a possible relationship but substantial inconsistency across studies, so PPI use should not be treated as proof of deficiency.
Focus on Older Patients and Multiple Medicines
Future research is likely to pay particular attention to older adults who take multiple medications, a group identified as having a major nutritional deficiency concern involving vitamin B12. One 2025 source specifically highlights older patients taking multiple medicines, including PPIs. Another report found that people with vitamin B12 deficiency were more likely to be taking PPIs and histamine 2 receptor antagonists, suggesting that medication patterns may be important targets for further study.
Interpreting Medication and Nutrition Evidence
The broader challenge is that vitamin B12 status can be studied through different measures and across populations with different medication patterns. Conflicting findings about PPIs make it difficult to infer individual risk from a single study or medication history. A cautious interpretation should distinguish an observed association from a confirmed cause and recognize that the evidence remains heterogeneous.
The Double-Trouble Case Scenario
A case study titled “PPIs and Metformin Leads to Deficiency” examines the potential consequences of taking both medications. It presents this combination as “double trouble” because the case focuses on their effects on vitamin B12. The report illustrates why medication combinations may matter in real-world discussions of deficiency, although a single case scenario cannot determine how often the same outcome occurs in the wider population.
While some experts believe routine screening isn't necessary for everyone on these medications, assessing your B-12 status before starting the medication and monitoring it periodically is a reasonable approach, especially for those with existing risk factors for deficiency.
Consider talking to your doctor about Vitamin B-12 supplementation. Since PPIs and H2RAs interfere with the absorption of B-12 from food, supplements can help bypass this issue. Oral supplements are safe and readily available. For those taking Metformin, it is important to test calcium levels and replenish calcium, along with consulting on B12 levels. Stay informed, work closely with your healthcare provider, and take proactive steps to maintain healthy Vitamin B-12 levels.